Biology of the Heparanase-Heparan Sulfate Axis and Its Role in Disease Pathogenesis
Overview
Hematology
Affiliations
Cell surface proteoglycans are important constituents of the glycocalyx and participate in cell-cell and cell-extracellular matrix (ECM) interactions, enzyme activation and inhibition, and multiple signaling routes, thereby regulating cell proliferation, survival, adhesion, migration, and differentiation. Heparanase, the sole mammalian heparan sulfate degrading endoglycosidase, acts as an "activator" of HS proteoglycans, thus regulating tissue hemostasis. Heparanase is a multifaceted enzyme that together with heparan sulfate, primarily syndecan-1, drives signal transduction, immune cell activation, exosome formation, autophagy, and gene transcription via enzymatic and nonenzymatic activities. An important feature is the ability of heparanase to stimulate syndecan-1 shedding, thereby impacting cell behavior both locally and distally from its cell of origin. Heparanase releases a myriad of HS-bound growth factors, cytokines, and chemokines that are sequestered by heparan sulfate in the glycocalyx and ECM. Collectively, the heparan sulfate-heparanase axis plays pivotal roles in creating a permissive environment for cell proliferation, differentiation, and function, often resulting in the pathogenesis of diseases such as cancer, inflammation, endotheliitis, kidney dysfunction, tissue fibrosis, and viral infection.
Sepsis-Induced Endothelial Dysfunction: Permeability and Regulated Cell Death.
Zhang W, Jiang L, Tong X, He H, Zheng Y, Xia Z J Inflamm Res. 2024; 17:9953-9973.
PMID: 39628705 PMC: 11612565. DOI: 10.2147/JIR.S479926.
Models of fibrolamellar carcinomas, tools for evaluation of a new era of treatments.
Song J, Lu M, He Z, Zhang W Front Immunol. 2024; 15:1459942.
PMID: 39582856 PMC: 11582006. DOI: 10.3389/fimmu.2024.1459942.
Mongiat M, Pascal G, Poletto E, Williams D, Iozzo R Proteoglycan Res. 2024; 2(3).
PMID: 39184370 PMC: 11340296. DOI: 10.1002/pgr2.22.
Insights into the Molecular Mechanism of Endothelial Glycocalyx Dysfunction during Heart Surgery.
Krsek A, Baticic L, Curko-Cofek B, Batinac T, Laskarin G, Miletic-Grskovic S Curr Issues Mol Biol. 2024; 46(5):3794-3809.
PMID: 38785504 PMC: 11119104. DOI: 10.3390/cimb46050236.
Yarimizu K, Nakane M, Onodera Y, Matsuuchi T, Suzuki H, Yoshioka M Clin Appl Thromb Hemost. 2023; 29:10760296231218711.
PMID: 38099709 PMC: 10725115. DOI: 10.1177/10760296231218711.